Ad-hoc Releases
Fast information flow: We keep you up to date on all company occurrences that could influence the share price significantly.
Key Information
Listed companies are obliged by law to publish without delay news of all company occurrences that could influence the share price significantly (Article 17 of the European Market Abuse Regulation (MAR)). We are committed to transparency and want to ensure that all capital market participants have access to key information about our company as quickly as possible, and thus prevent insider dealing due to any information asymmetry.
Shareholders
Read MoreShareholders
Directors' Dealings
Read MoreDirectors' Dealings
Voting Rights Notifications
Read MoreVoting Rights Notifications
Related News
View All News-
Press Releases
Pimicotinib Significantly Improved Outcomes for Patients with TGCT in Phase ...
Phase III MANEUVER trial of pimicotinib met its primary endpoint, demonstrating significant improvement in objective response rate in TGCT-patients.
2024/11/12